Literature DB >> 12614452

Induction of allergic inflammation in the lungs of sensitized sheep after local challenge with house dust mite.

R J Bischof1, K Snibson, R Shaw, E N T Meeusen.   

Abstract

BACKGROUND: Previous sheep models of asthma are based on sheep sensitized to nematode (Ascaris) allergens and these have been used to evaluate the physiological and pharmacological effects of potential anti-asthma agents. The immunological mechanisms associated with the allergic response in sheep lungs has not been examined in detail.
OBJECTIVE: To develop an experimental sheep model of allergic lung inflammation based on a relevant major human allergen, house dust mite, and to define the immunological features of the allergic response in this model.
METHODS: Sheep immunized subcutaneously with solubilized house dust mite extract were given a single bronchial challenge with house dust mite. Bronchoalveolar lavage (BAL) and peripheral blood leucocytes were collected before and after challenge for flow cytometry, and tissue samples were taken post-mortem (48 h post-challenge) for histology and immunohistochemical analyses.
RESULTS: Immunizations with 50 microg house dust mite induced an allergen-specific IgE response in 50 to 60% of sheep (allergic sheep), with higher antigen doses increasing specific IgG1 but not IgE. Lung challenge of allergic sheep with house dust mite led to the initial recruitment of neutrophils (at 6 h post-challenge) followed by eosinophils and activated lymphocytes into the lung tissue and BAL, similar to the late-phase allergic response seen in human asthma. Eosinophil recruitment peaked at 48 h post-challenge, representing 10 to 33% of BAL leucocytes in allergen-challenged allergic sheep compared to 0 to 3% in allergen-challenged control (naïve) sheep. Lymphocytes recovered from the lung after allergen challenge were enriched for CD4+ T cells and were more activated than lymphocytes in blood. There was significant down-regulation of CD62L (L-selectin) and CD49d (VLA-4) expression after allergen challenge on BAL eosinophils and lymphocytes compared to blood. In addition, VCAM-1 (ligand for VLA-4) was up-regulated on blood vessels of allergen-challenged lungs. Eosinophils, CD4+ T cells and CD45R+ B cells were the most prominent leucocytes found in lung tissue 48 h after allergen challenge.
CONCLUSION: This study demonstrates, for the first time, the ability of house dust mite to induce allergic responses in sheep lungs. This novel sheep model of allergic lung inflammation using relevant human allergens, exhibits similarities to human asthmatic disease and will be a useful tool for studies of the immunological and physiological mechanisms of allergic asthma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614452     DOI: 10.1046/j.1365-2222.2003.01534.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  23 in total

1.  The innate response to peanut extract in ovine afferent lymph and its correlation with allergen sensitisation.

Authors:  Jenna L Van Gramberg; Robert J Bischof; Robyn E O'Hehir; Michael J de Veer; Els N Meeusen
Journal:  Immunol Cell Biol       Date:  2015-02-10       Impact factor: 5.126

2.  Development of an in vivo ovine dry powder inhalation model for the evaluation of conventional and controlled release microparticles.

Authors:  Rania O Salama; Leigh Ladd; Hak-Kim Chan; Daniela Traini; Paul M Young
Journal:  AAPS J       Date:  2009-07-01       Impact factor: 4.009

3.  Placental restriction of fetal growth reduces cutaneous responses to antigen after sensitization in sheep.

Authors:  Amy L Wooldridge; Robert J Bischof; Els N Meeusen; Hong Liu; Gary K Heinemann; Damien S Hunter; Lynne C Giles; Karen L Kind; Julie A Owens; Vicki L Clifton; Kathryn L Gatford
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-05       Impact factor: 3.619

4.  A new approach for analyzing cellular infiltration during allergic airway inflammation.

Authors:  Peter R Hoffmann; Alexandra Gurary; Fukun W Hoffmann; Claude Jourdan-Le Saux; Kelsa Teeters; Ann C Hashimoto; Elizabeth K Tam; Marla J Berry
Journal:  J Immunol Methods       Date:  2007-08-27       Impact factor: 2.303

5.  An ovine tracheal explant culture model for allergic airway inflammation.

Authors:  Latasha Abeynaike; Els Nt Meeusen; Robert J Bischof
Journal:  J Inflamm (Lond)       Date:  2010-08-30       Impact factor: 4.981

6.  Development of an experimental model of maternal allergic asthma during pregnancy.

Authors:  Vicki L Clifton; Timothy J M Moss; Amy L Wooldridge; Kathryn L Gatford; Bahar Liravi; Dasom Kim; Beverly S Muhlhausler; Janna L Morrison; Andrew Davies; Robert De Matteo; Megan J Wallace; Robert J Bischof
Journal:  J Physiol       Date:  2015-09-02       Impact factor: 5.182

7.  Late-gestation maternal dietary methyl donor and cofactor supplementation in sheep partially reverses protection against allergic sensitization by IUGR.

Authors:  Amy L Wooldridge; Robert J Bischof; Hong Liu; Gary K Heinemann; Damien S Hunter; Lynne C Giles; Rebecca A Simmons; Yu-Chin Lien; Wenyun Lu; Joshua D Rabinowitz; Karen L Kind; Julie A Owens; Vicki L Clifton; Kathryn L Gatford
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-10-04       Impact factor: 3.619

8.  The effect of human amnion epithelial cells on lung development and inflammation in preterm lambs exposed to antenatal inflammation.

Authors:  Paris Clarice Papagianis; Siavash Ahmadi-Noorbakhsh; Rebecca Lim; Euan Wallace; Graeme Polglase; J Jane Pillow; Timothy J Moss
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

9.  Use of animal models to investigate major allergens associated with food allergy.

Authors:  Jenna L Van Gramberg; Michael J de Veer; Robyn E O'Hehir; Els N T Meeusen; Robert J Bischof
Journal:  J Allergy (Cairo)       Date:  2013-04-11

10.  Induction of allergic responses to peanut allergen in sheep.

Authors:  Jenna L Van Gramberg; Michael J de Veer; Robyn E O'Hehir; Els N T Meeusen; Robert J Bischof
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.